20 LATEST RESOURCES (249 INDEXED)
×
Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram · February 2024
Articles
Therapeutics and Clinical Risk Management
×
Electroacupuncture versus Escitalopram for Mild to Moderate Post-Stroke Depression: A Randomized Non-Inferiority Trial · February 2024
Articles
Frontiers in Psychiatry
×
Functional Neuroimaging Biomarkers of Anhedonia Response to Escitalopram Plus Adjunct Aripiprazole Treatment for Major Depressive Disorder · January 2024
Articles
BJPsych Open
×
Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder · December 2023
Articles
Journal of Child and Adolescent Psychopharmacology
×
Cardiovascular Adverse Reactions Associated with Escitalopram in Patients with Underlying Cardiovascular Diseases: A Systematic Review and Meta-Analysis · September 2023
Articles
Frontiers in Psychiatry
×
Pilot Study of Genome-Wide DNA Methylation and Gene Expression for Treatment Response to Escitalopram in Panic Disorder · August 2023
Articles
World Journal of Psychiatry
×
Clinical Efficacy of Escitalopram Combined with Botulinum Toxin A in Patients with Generalized Anxiety Disorder and Comorbid Headache · July 2023
Abstracts
Psychopharmacology
×
Association between Plasma Metabolic Profiles of the Antidepressant Escitalopram and Clinical Response in Subjects with Depression · June 2023
Articles
Mass Spectrometry
×
Feasibility, and Barriers to Use Escitalopram in Functional Gastrointestinal Disorders · May 2023
Articles
Frontiers in Pharmacology
×
Low Escitalopram Concentrations in Patients with Depression Predict Treatment Failure: A Naturalistic Retrospective Study · March 2023
Articles
Pharmacopsychiatry
×
Impact of Sertraline, Fluoxetine, and Escitalopram on Psychological Distress among United States Adult Outpatients with a Major Depressive Disorder · March 2023
Articles
Healthcare
×
Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-Blinded 6-Week Clinical Trial · February 2023
Articles
Clinical Psychopharmacology and Neuroscience
×
Effects of 12-Week Escitalopram Treatment on Resting-State Functional Connectivity of Large-Scale Brain Networks in Major Depressive Disorder · February 2023
Articles
Human Brain Mapping
×
Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients with Major Depressive Disorder · January 2023
Articles
Biological Psychiatry Global Open Science
×
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults with Anxiety Disorders: A Randomized Clinical Trial · November 2022
Articles
JAMA Psychiatry
×
Systematic Review and Meta-Analysis on the Therapeutic Reference Range for Escitalopram: Blood Concentrations, Clinical Effects and Serotonin Transporter Occupancy · October 2022
Articles
Frontiers in Psychiatry
×
Concentrations of Escitalopram in Blood of Patients Treated in a Naturalistic Setting: Focus on Patients with Alcohol and Benzodiazepine Use Disorder · October 2022
Articles
European Archives of Psychiatry and Clinical Neuroscience